Reversal Reaction in A Borderline Lepromatous Leprosy Patient after COVID-19 Vaccine: Prevention or Risks?. J Pak Assoc Dermatol [Internet]. 2022 Aug. 27 [cited 2026 Jul. 10];32(3):609-12. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1953